Public trial
RBR-3b7rqpv Early detection of acute kidney injury in patients undergoing cardiac surgery
Date of registration: 07/01/2026 (mm/dd/yyyy)Last approval date : 07/01/2026 (mm/dd/yyyy)
Study type:
Observational
Scientific title:
en
Early detection of acute kidney injury in patients undergoing cardiovascular procedures: clinical assessment based on renal tubular physiology and biomarkers.
pt-br
Detecção precoce de injúria renal aguda em pacientes submetidos a procedimentos cardiovasculares: avaliação clínica baseado em fisiologia tubular renal e biomarcadores
es
Early detection of acute kidney injury in patients undergoing cardiovascular procedures: clinical assessment based on renal tubular physiology and biomarkers.
Trial identification
- UTN code: U1111-1339-6104
-
Public title:
en
Early detection of acute kidney injury in patients undergoing cardiac surgery
pt-br
Detecção precoce de lesão renal aguda em pacientes submetidos à cirurgia cardíaca
-
Scientific acronym:
-
Public acronym:
-
Secondaries identifiers:
-
62492022.6.0000.0048
Issuing authority: Plataforma Brasil
-
6.767.765
Issuing authority: Comitê de Ética em Pesquisa do Hospital São Rafael
-
62492022.6.0000.0048
Sponsors
- Primary sponsor: Hospital São Rafael
-
Secondary sponsor:
- Institution: Hospital Aliança
-
Supporting source:
- Institution: Hospital São Rafael
Health conditions
-
Health conditions:
en
Acute Kidney Injury
pt-br
Injúria Renal Aguda
-
General descriptors for health conditions:
en
H02.403.810.803 Thoracic Surgery
pt-br
H02.403.810.803 Cirurgia Cardíaca
-
Specific descriptors:
en
C12.050.351.968.419.780.050 Acute Kidney Injury
pt-br
C12.050.351.968.419.780.050 Injúria Renal Aguda
Interventions
-
Interventions:
en
This is a prospective observational study, without a control group and without intervention. Patients undergoing cardiac surgery, after signing an informed consent form, had baseline (pre-procedure) blood and urine samples collected, and again 4 hours after surgery. Renal tubular phosphorus transport was evaluated through calculations of excreted load, maximum phosphorus transport, and maximum phosphorus transport normalized by glomerular filtration. In addition, serum levels of the biomarker fibroblast growth factor 23 (FGF-23) and urinary levels of the biomarker neutrophil gelatinase-associated lipocalin (NGAL) were also measured as early markers of acute kidney injury.
pt-br
Trata-se de um estudo observacional prospectivo, sem grupo controle e sem intervenção. Pacientes submetidos a cirurgias cardíacas, após termo de consentimento assinado, tiveram coleta de sangue e urina basal (pré procedimento) e 04 (quatro) horas após a cirurgias. Foram avaliados, desta forma, o transporte tubular renal de fósforo através de cálculos de carga excretada, transporte máximo de fósforo e trasnporte máximo de fósforo normatizado pela filtração glomerular. Além disso houve dosagens sérica do biomarcador fator de crescimento de fibroblastos 23 (FGF-23) e urinária do biomarcador lipocalina associada à gelatinase de neutrófilos (NGAL) também como marcadores precoces de lesão renal aguda.
-
Descriptors:
en
D12.776.124.050.475 Lipocalin-2
pt-br
D12.776.124.050.475 Lipocalina Associada a Gelatinase de Neutrófilo
Recruitment
- Study status: Recruitment completed
-
Countries
- Brazil
- Date first enrollment: 10/11/2022 (mm/dd/yyyy)
-
Target sample size: Gender: Minimum age: Maximum age: 70 - 18 Y 80 Y -
Inclusion criteria:
en
Age over 18 years; Patients undergoing complex cardiac surgical procedures (cardiac surgeries using extracorporeal circulation or complex percutaneous valve repair) and vascular procedures (complex peripheral vascular revascularization surgeries); Possibility of accurate measurement of urine output for at least 24 hours after the procedure; Consent to participate in the study or a legally authorized representative who can legally consent
pt-br
Idade acima de 18 anos; Pacientes submetidos a procedimentos cirúrgicos cardíacos complexos (cirurgias cardíaca com utilização de circulação extracorpórea ou percutâneo complexo valvar) e vasculares (cirurgias de revascularização vascular periférica complexas); Possibilidade de correta mensuração de diurese por pelo menos por 24h após o procedimento; Consentir em participar do estudo ou representante legal que possa, legalmente, consentir
-
Exclusion criteria:
en
Patients with estimated creatinine clearance < 30 ml/min; History of kidney transplant; Obstructive uropathy; Acute kidney injury (any grade) at the time of randomization; History of parathyroidectomy; History of hyperparathyroidism or hypoparathyroidism; History of active neoplasia; Anuria
pt-br
Pacientes com Clearance de creatinina estimado < 30ml/min; História de transplante renal; Uropatia obstrutiva; Lesão renal aguda (em qualquer grau) no momento da randomização; História de Paratireoidectomia; História de Hiperparatireoidismo ou Hipoparatireoidismo; História de neoplasia ativa; Anúria
Study type
-
Study design:
-
Expanded access program Purpose Intervention assignment Number of arms Masking type Allocation Study phase
Outcomes
-
Primary outcomes:
en
This study is expected to identify increased renal tubular transport of phosphorus, defined as a fractional excretion of phosphorus greater than 15% after 4 hours of the procedure, more strongly associated with patients who developed acute kidney injury during hospitalization according to KDIGO (Kidney Disease: Improving Global Outcomes) criteria
pt-br
Espera-se no presente estudo a identificação de transporte tubular renal de fósforo aumentado, definido como fração de excreção de fósforo maior que 15% após 4h do procedimento, em maior associação com pacientes que desenvolveram lesão renal aguda na internação de acordo com critérios do KDIGO (Kidney Disease: Improving Global Outcomes)
-
Secondary outcomes:
en
Length of hospital stay, in-hospital death, need for hemodialysis, and changes in the biomarkers serum Fibroblast Growth Factor 23 (FGF-23) and urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) 4 hours after surgery will be evaluated
pt-br
Serão avaliados o tempo de hospitalização, óbito na internação, necessidade de hemodiálise, alteração em biomarcadores Fator de Crescimento de Fibroblastos 23 (FGF-23) sérico e Lipocalina associada à gelatinase neutrofílica (NGAL) urinário após 4 horas da cirurgia
Contacts
-
Public contact
- Full name: Marcelo Augusto Duarte Silveira
-
- Address: rua do benjoim, 71, apto 502
- City: Salvador / Brazil
- Zip code: 41820-340
- Phone: +55(71)99970-6175
- Email: marceloadsilveira@gmail.com
- Affiliation: Hospital São Rafael
-
Scientific contact
- Full name: Marcelo Augusto Duarte Silveira
-
- Address: rua do benjoim, 71, apto 502
- City: Salvador / Brazil
- Zip code: 41820-340
- Phone: +55(71)99970-6175
- Email: marceloadsilveira@gmail.com
- Affiliation: Hospital São Rafael
-
Site contact
- Full name: Marcelo Augusto Duarte Silveira
-
- Address: rua do benjoim, 71, apto 502
- City: Salvador / Brazil
- Zip code: 41820-340
- Phone: +55(71)99970-6175
- Email: marceloadsilveira@gmail.com
- Affiliation: Hospital São Rafael
Additional links:
Total de Ensaios Clínicos 18505.
Existem 9395 ensaios clínicos registrados.
Existem 5117 ensaios clínicos recrutando.
Existem 110 ensaios clínicos em análise.
Existem 6158 ensaios clínicos em rascunho.